When will immunomodulation for the prevention of type 1 diabetes be a reality?
Leech
N J
NJ
Newcastle Diabetes Centre, Newcastle-upon-Tyne, UK.
D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051379:Mice; D016688:Mice, Inbred NOD; D011322:Primary Prevention
D000941:Antigens